Caxton Associates (New York)’s iPath Series B S&P 500 VIX Short-Term Futures ETN VXX Stock Holding History
Bought
Maintained
Sold
Other funds holding VXX
CA
Caxton Associates (New York)'s VXX Position: Q2 2021 in Review
Caxton Associates (New York) sold out of iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) in Q2 2021, closing a stake of 27 shares — an estimated $16.1K sold.
Caxton Associates (New York) first reported a position in VXX in Q1 2021 and held it in 1 quarter. The position peaked at $19K in Q1 2021. 114 funds tracked by Wall St. Rank hold VXX as of Q2 2021.
- Caxton Associates (New York) reported no remaining iPath Series B S&P 500 VIX Short-Term Futures ETN position as of Q2 2021 after selling out during the quarter.
- Caxton Associates (New York) sold 27 iPath Series B S&P 500 VIX Short-Term Futures ETN shares in Q2 2021, an estimated $16.1K.
- Caxton Associates (New York) first reported a position in iPath Series B S&P 500 VIX Short-Term Futures ETN in Q1 2021 and held it in 1 quarter.
- Caxton Associates (New York)'s iPath Series B S&P 500 VIX Short-Term Futures ETN position peaked at $19K in Q1 2021.
- 114 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Short-Term Futures ETN as of Q2 2021.
Based on Caxton Associates (New York)'s 13F filing for Q2 2021, filed 16 Aug 2021.